NCT00501943 Neuroprotection With Riluzole Patients With Early Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00501696 A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone Status COMPLETED Phase PHASE3
NCT00497952 Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis Status WITHDRAWN Phase PHASE1/PHASE2
NCT00493077 Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy Status COMPLETED Phase PHASE4
NCT00492765 Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00490906 Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis Status COMPLETED Phase N/A
NCT00489489 Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00488839 IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00484536 Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 Status TERMINATED Phase PHASE2
NCT00483847 TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World Status COMPLETED Phase N/A
NCT00483652 Study of Fampridine-SR Tablets in Multiple Sclerosis Patients Status COMPLETED Phase PHASE3
NCT00480181 Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00475865 Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00469378 Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00468182 Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis Status COMPLETED Phase N/A
NCT00467584 Aspirin for Treatment of Multiple Sclerosis-Related Fatigue Status TERMINATED Phase PHASE3